Ko te tarukino "Aspekard": tohutohu mō te whakamahi, analogs, arotake

waikawa ahipirini (ASA) e pā ana ki taero ki ngā pānga antipyretic, anti-inflammatory me antiplatelet. I roto i te mahi hauora te whakamahia reira nui atu i 125 nga tau, no te mea ko tetahi o te raau taero tino ako. Ai te mea i teie nei e wātea ana ASA rite ki he kardioformy whakaiti i te mōrea o te Thrombosis te AVC, e faataupupû i te whanaketanga o te infarction myocardial. He tauira angamaheni ko te faaineineraa "Aspekard" e kei waikawa ahipirini i roto i te tino pai horopeta mō pānga antiplatelet.

Mōhiohio i runga i te puka tuku, me te Manufacturer

Ko te kaihanga o te tarukino ko te kamupene Ukrainian "Stirolbiopharm". Nä, ko te ahumahi hangarau e whakamahia ana, whakaputaina i roto i te puka puka zheludochnorastvorimoy i te horopeta o 100 mg ia papa. Methods Papa tahora:

• kātene 120 papa (10 ki te 12 opupu ripa.);
• ipu polymeric 100 papa.

Tablet "Aspekard" kei roto 100 mg o ASA, microcrystalline cellulose, te konutai croscarmellose, te hauhā silicon colloidal, waikawa nenehake.

Tūtohutanga mō te whakarite

I roto i te faaineineraa "Aspekard" he kuiti nui tono, ahakoa kei reira te tohutohu mō tūtohutanga mō te maimoatanga o maha mate, tae atu ki ngā mate rūmātiki. Manufacturer tūtohu "Aspekard" me rite te kaihoko antipyretic analgesic ranei. I roto i te meka, taea anake te tōtika te whakamahi i roto i te inenga o te rongoa waikawa ahipirini rite te tarukino e ārai mōtepe whakahiato.

Tuhinga "Aspekard"

I te faaineineraa "Aspekard" ako i runga i te tono, arotake ngaio rangahau haumanu, me te hoatu i te rota o te mōhiohio e pā ana ki te antiplatelet therapy. Kei te tohua te reira i roto i te mau huru e whai ake nei:

• ka (ACS), syndrome coronary whakapeka (i taahiraa poipoi whakapeka myocardial infarction, whārua tonu ST tauwāhi wāhanga ranei, i roto i te angina iu);
• ki patu (patunga rere pūroto whawhai rere pūroto rangitahi ranei);
• i roto i te take o kï mate te AVC rite te tikanga o te ārai o whakapeka syndrome coronary me te patu;
• i roto i te ārai o wā recurrent o whakapeka syndrome coronary me te patu;
• ki te aroaro o uaua tīponapona;
• rite te māngai ārai, he Thrombosis whakatūpato whakanekeneke i muri CABG;
• ki te takawhita i roto i te take o te tūpono Cardiovascular tiketike.

High mōrea Cardiovascular ko te ariā whakahiato e ngā te aroaro o te ūnga kino okana i roto i takawhita me mate e pā ana: mate huka mellitus, mate te AVC, TSVB.

Āhuatanga regimens inenga tūtohutia e te kaiwhakanao

I roto i te faaineineraa e kore ko te ārahitanga matua o te maimoatanga o te manawanui "Aspekard" ako kaihanga. Kei te reira i ngā mōhiohio e pā ana ki te whakahaere o te raau taero i roto i te rerekē ngā āhuatanga haumanu kopikopiko i te ārai o ngā atherothrombotic i CHD me TSVB me whakamutu ki disorders whakapeka o tohanga kaka, me te ngakau. whakaaro ana tēnei mahue te huru e mangere me te kāhore ki te take o te raau taero, me ratou rauemi mōhiohio tahi. Reira hanga ano nga preconditions mō whakaputanga papatipu o ngā tuhinga i roto i nei rerekē te toketaá tūtohutia.

Dosing regimens i runga i te pūtake o ngā tūtohutanga ao

I runga i te pūtake o ngā aratohu ao whakawhanakehia e te Hapori Pākehā o Cardiology (ESC) me te American Heart Association (AHA) ka takatūria e te Tāhuhu o te Hauora, te aratau o tono o te waikawa ahipirini he rite whai:

• i roto i te taahiraa whawhati tata i roto i syndrome coronary whakapeka hiahiatia te ki hoatu te manawanui ki tararua ana te papa 3 "Aspekard 100". Kei te waiho tohutohu mō te whakamahi, me te horopeta kotahi o 300 mg;
• ischemia ma'i cardiac (CHD) i fariiraa tamau whakaritea tetahi papa o 100 mg i roto i te ahiahi i muri tina;
• ki te takawhita tūroro i te mōrearea nui o pōauautanga Cardiovascular, me te tētere venous tonu whāngai e 100 mg (1 papa) i roto i te ahiahi i muri i te tamaaraa.

Ētahi atu ara o te whakahaere tarukino "Aspekard" ESC ako me AHA kore e whakarato. He mea nui hoki ki te mōhio e te horopeta paerewa "Aspekard" ko 100 mg o ASA. Hoki te ārai o te mate i runga, i runga i tohutohu ESC me AHA, tono horopeta o 75 mg. Heoi, 100 mg whakaritea tūroro i muri i CABG ki te ārai Thrombosis o te whakanekeneke. I roto i te tahi atu te wā tūtohutia reira ki te tono 75 mg, i.e. te nui o ASA, e whakarato ana pānga antiplatelet rawaka me te he gastrotoxicity mōrearea iti.

Ano, e kore e te kaiwhakanao whakarato ngā mōhiohio nui i runga i te whakakāhoretanga o te tarukino. E ai ki ngā tatauranga, te mutunga ohorere o te take o 10.2% o ngā Cardiovascular whakapeka. A e kitea e ratou i muri i nga ra tata 10.6 i te rā o te whakakorenga o ASA. Tenei wā ko te toharite, me te whakaata i te wa i roto i i heke te taupori katoa te mōtepe cyclooxygenase mahi. Ka rite ki te hua, te taea o clots toto faaho'ihia mai. No te mea te tarukino me tangohia tonu, i hiahiatia te whakarite o tetahi atu kaihoko antiplatelet hei utu o "Aspekard" ahua o pōauautanga i te wahi gastrointestinal te.

Contraindications "Aspekard" teuteu

He whanaunga te haumaru o ngā hua rongoā katoa, no te mea kua ratou pānga taha. I te wa ano meinga ratou etahi contraindications. I roto i te ngā:

• i roto i disorders o coagulation toto (hemorrhagic diathesis, hemophilia A me te B);
• i roto i disorders o te āhuatanga puku (erosions, tuwhenua whakapeka o te puku, me te duodenum 12);
• i roto i te huatū tuatahi o te hapū me te hohipera;
• i roto i te kino waimaero tākihi ate ranei;
• ka tauhohe mate pāwera ki salicylates;
• i roto i ngā tamariki teina atu 18 tau;
• i roto i te aroaro o te huangō arahau;
• i roto i te maimoatanga o te methotrexate.

He pū ēnei contraindications, ahakoa etahi wa: hohipera, hapūtanga, horo me tuwhenua o te wahi gastrointestinal, kōhungahunga. Na hoki i reira ko te rōpū o āhua, te aroaro o e titau aroturuki tamau e te tākuta. Tenei whakamahi tukutahi o antiplatelet therapy ki anticoagulants, me te maimoatanga o te tūroro i muri i coronary pokanga uaua karo. Ki te tono te mahi tākihi ki te tarukino "Aspekard" tohutohu mō te whakamahi rapu inenga whakaiti whakaoti i te whakakāhoretanga āta o te tarukino ranei.

pānga Tahi "Aspekard"

he maha o ngā pānga e whakarei ake lōmekina te mahi o te maha taero ranei waikawa ahipirini kua. I roto i te ngā:

• whakarei ake ASA te pānga o tetahi anticoagulants me āpiha antiplatelet;
• whakatairanga ASA pānga antipyretic me analgesic o NSAIDs, ee faarahi ho'ii pānga antirheumatic "Meloxicam";
• ka ngā ki taero cytotoxic whakarei ratou gastrotoxicity;
• ka tango ki waipiro te mōrea o fifi whewhe piki toto ranei;
• glucocorticoids hua gastrotoxicity "Aspekard";
• Ack attenuates pānga diuretic ka ngā ki Diuretics "Furosemide", "torasemide", "spironolactone".
• "Aspekard" ka ngoikore te pānga o āpiha uricosuric, "Probenecid", "Etamid", "sulfinpirazon";
• nonabsorbable waikawa tino whakaiti i te absorption o "Aspekard".

Ko te tūponotanga o te tuwhena rawa, me ona tohu

Āhua raau "Aspekard" ako, urupare me te whakamahi o te tatauranga whakau te nui taumata tiketike o te haumarutanga i te fariiraa rite ki tohu me contraindications okotahi. Tenei te tikanga e he haumaru nui te horopeta whakaritea o 100 mg o te tarukino, ahakoa ko te mana o te āhua o te hauora e tika ana. Ano, i roto i te tirohanga o te ropu o te tūroro ki te mau hinaaro suicidal, rite pai rite te mōrea e ka tangohia nga papa o ASA te tamaiti, taipitopito e hiahiatia tuwhena rawa tūponotanga me ona tohu.

salicylates poisoning ngawari, whakapataritari i te tono o te faaineineraa "Aspekard" kahore he tūtohutanga tākuta tohu ko nga āhua e whai ake nei: whanoke, mamae i roto i te podlozhechkovoy fossa, te rohe pito, i ētahi wā mamae, rawa i roto i tūroro ki te mate tākihi. I roto i te take o te tuwhena rawa rite reira te Mongamonga, ruaki, i ētahi wā ki te whai koputaputa he toto. Ko te tuatahi Ko mā te whakaurutanga mai tāwhaiwhai o emesis: inu matao nui, tikanga waro whakahohe me ehnterosorbentov manawanui tuku i roto i te fare ma'i.

Mea nui, ko te pota paitini "Aspekard" ā-ako e kore e whakapūtā. He rerekē hoki te taimaha rerekē, me te tau o te manawanui ratou. Hei tauira, i roto i te pakeke tangata tohu ngawari tuwhena rawa ASA puta i whakauru kotahi waikawa e pā ana ki 5-7 karamu. E nui tamariki mo te tuwhena rawa o 1.5 g whängainga kotahi. puta te tuwhena rawa nui ka tono 7-9 karamu o ngā pakeke me ngā tamariki 2-2.5 karamu ASA.

Tenei tohu o te tuwhena rawa raau whakakitea e te disorders runga ake e whai wāhi mai ngā mahi-hinengaro. tīmata tuhipoka ngaro raruraru tinnitus whakaaro tau ana, korero incoherent. Ruaki maha tupu, te manawanui hohoro te ngaro inu i ruaki, whakaora manawa, i reira he pupuri mimi whakapeka, nui haere te pāmahana tinana. Āwhina i te manawanui i roto i te āhuatanga i taua he e taea te reira ki te takitahi - hiahiatia tuku e i roto i te NICU mō whaowhia therapy hauwai pākawa, te konutai lactate.

Āhuatanga o te mahi whakaora "Aspekard"

Āpitihia ki te tarukino "Aspekard" mahi ako Kei roto he tohu o te fariiraa o tetahi papa ia ra (100 mg / ra). Tenei horopeta ASA he ranea ki te tautāwhi i mōtepe cyclooxygenase. Ko te hua, ko te inhibition o ariā o thromboxane A2, e tino inhibits te kaha o ngā pūtau ki mōtepe whakahiato. Faaore i te taea o te Thrombosis, i te mea te take o te infarct myocardial kaka ranei.

Hei whakarato i te pānga antithrombotic o te waikawa ahipirini kia whenumi ki te toto. Heoi, mahi etahi o reira i roto i te kopu, me te hëoi hoki cyclooxygenase-1 me ona isoforms i te mucosa o te okana. Ko te hua o tenei huarahi ko te pānga taha - kaha heke muco-tiaki arai pākawa waro. faarahi tenei nga mōrea o erosions me mariao o te puku, whakaongaonga gastrointestinal-toto. He formulations Enteric hoki e taea ki te kaha ai te toto, engari te auau o tenei pānga taha, i ratou tino iti.

Pregnancy me te hohipera

whakaaro tohunga, i runga i te aro mātai tauanga me te raupapa o ngā, tuku ki a koutou i te mārama māramatanga o te tono o "Aspekard" te raau taero i roto i te hapū. I roto i ngā, rāhuitia 1 huatū tona whakamahinga te. I 2 me 3 huatū tukua tono te, engari i muri i te aro mātai o tona whakamahi whakaora, me te whakatairite i te tūponotanga fariiraa. I roto i te nuinga nui o haumanu ASA āhuatanga whakarite faufaa ore, ahakoa taea ki te whakapiki ake i te mōrearea o te materoto e hoki atu NSAIDs.

I roto i te hohipera, te whakamahi i te tarukino "Aspekard" analogues ia, arowhānui, me te rongoā katoa ki te waikawa ahipirini i roto i te hanganga rāhuitia te. Ko te take hoki tenei ko ki te patu i te tarukino i roto i te waiu uma. ô i te reira ia tae noa ki roto i te tinana o te tamaiti. Na tona ati ko mōrearea nui o whakawhanake syndrome o Reye - he encephalopathy ate tino nui, e ai roro huamo me te mate o te tamaiti. No te take ōrite, rāhuitia whakamahi o te raau taero i te aroaro o te tau o 16-18 tau.

Whakatakotoranga Reviews ngaio me tūroro

Characterizing te tarukino "Aspekard" urupare manawanui i roto i te maha ngā take rītaha. aromatawaitia pai ratou te utu o te tarukino, mai te mea te reira tata te raro i roto i hoa. Heoi, kōrero e pā ana ki te tono mahi o iti te tohu o te ngoikore ki te aromatawai i te tohu o tūroro whakaiti te mōrea o te Thrombosis iaia. I roto i ngā o ngā pānga taha korerotia e tūroro, āhuatanga te raau e rite haumaru makona.

He whakaaro o tohunga mārama: tuatahi, he whai hua i roto i te whakaiti i te mōrea o te Thrombosis te raau taero, a tuarua, talangofua tūroro ki antiplatelet he teitei therapy no o te iti "Aspekard" utu o te tarukino. Analogs o te piha haapiiraa o āpiha antiplatelet he tino teitei. faaineineraa kāinga enteric "Atsekardol" atu te utu i te 50%, i te utu o kawemai teitei e 7-10 wā. Ko e hāngai ana i runga i iti pānga taha āpiha enteric, me te te kitenga ōhanga, he reira e minaminatia ki te hoatu matua ki "Atsekardolu". Ko te utu o te maimoatanga marama ka kia e pā ana ki 20 moni.

Ko te kore whāinga o te kardiopreparata "Aspekard"

Āpitihia ki te tarukino "Aspekard 100" ā-ako ta e he wātea i roto i papa te tarukino. tareka ratou i roto i te kopu, me te hua i te kukū tiketike. Whakarato pānga gastrotoksichesky rohe, ngaro te tarukino Haumaru Ētahi atu taero, ara enteric. mōrea toto pekitīlia ka tono te muri, ko te iti rawa iho.

Tauira o taero haumaru e whai ake nei: "Atsekardol", "Polokard", "Cardiomagnyl", "ahipirini manawa." Ano, ka mea Kei roto ano tikanga waihā konupora, taea ki te tiaki i te mucosa i whara i te waikawa ahipirini. Otiia, i te tarukino "Aspekard" kia te whakamahi mo te ārai o thrombus hanganga, ahakoa ki te here. Heoi, tūroro he horo mucosal, whewhe 12 duodenum puku ranei, tae atu i te ma'i, e tūtohu ana ki te tango i kardioformy waikawa ahipirini enteric.

Vneotraslevoe kardiopreparata tono "Aspekard"

Te nuinga o te wātea ana tohutohu mō te whakamahi tohu i te aroaro antiinflammatory me āhuatanga antipyretic tarukino "Aspekard 100". I roto i te meka, he pānga haumanu rongoa tonu ko 5 nga wa te horopeta kotahi - 500 mg. Ko anake cardiac te inenga o 100 mg, a kahore he ranea ki tōtika whakaiti pāmahana i roto i ngā mate hopuhopu tona pānga.

Kardioforma faaineineraa hangaia i roto i te horopeta o 100 mg, he e tika ana mō te mamae, me te te tauturu kirika anake ki horopeta kotahi o 5 papa. Ko te kupu selectivity predominance mō te cyclooxygenase 1 whakatau te aroaro o te plurality o tauhohe taha. Na reira, ka rite ki te febrifuge "Aspekard" pire, o te akoranga, e tika ana. Heoi, i te kau i reira e he maha o te maha o taero haumaru whakaahua selectivity nui hoki cyclooxygenase 2. ratou ano i iti pānga taha e pā ana ki te tūkino o te tini o te epithelium gastrointestinal.

Haumaru ritenga piha "Aspekard" tarukino

kitea te au rite i roto i te maimoatanga o mate rūmātiki. A piri ki te tarukino kei "Aspekard" ako mō te whakamahi mōhiohio e pā ana ki to ratou maimoatanga. Heoi, ko te horopeta tūtohutia o te tikanga o 5-8 karamu ia ra.

Tenei nui o te waikawa ahipirini whakaatu pānga gastrotoxicity ta'e kaha atu i ka "meloxicam" Pharmaceuticals, "celecoxib", "Roferoksib" me etahi atu. A rite antipyretic orotahi tino faufaa piha ko "Ibuprofen".